Ubrelvy 100 MG tablet UD 16S
Ended Awarded Last action
- Contract number
- SPE2DR26FXUB4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $80,750
Award facts
- Contract value 100% obligated
- $80,750.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $80.8K delivery order to AmerisourceBergen Drug Corp for UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging on January 15, 2026, with completion targeted for January 16, 2026. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $1B through December 2026), which serves as the primary vehicle for pharmaceutical supply to military healthcare systems globally. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania—the location of performance for this award—and supplies an extensive portfolio of medications across multiple therapeutic domains to federal military and veteran healthcare programs.
UBRELVY is a migraine abortive medication indicated for acute treatment, reflecting the ongoing pharmaceutical supply needs of the Defense Health Agency and military treatment facilities. The delivery order structure with firm fixed pricing demonstrates the efficiency of DLA's indefinite delivery contracting approach for routine pharmaceutical procurement. As a non-set-aside award, this order was competed on a full and open basis through DLA's established vendor network, with AmerisourceBergen continuing to serve as a critical supplier of specialized medications and medical commodities to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FXUB4?
SPE2DR26FXUB4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FXUB4 worth?
The government has obligated $80,750 on SPE2DR26FXUB4.
Is contract SPE2DR26FXUB4 an order under another contract?
Yes. SPE2DR26FXUB4 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUB4 competed?
The extent of competition for SPE2DR26FXUB4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award